Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts

American Journal of Physiology - Endocrinology and Metabolism

Volumn 277, Issue 3 40-3, 1999, Pages

  Pereira, Renata C ^a,b   Jorgetti, Vanda ^b   Canalis, Ernesto ^a,c  

^a SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Bone remodeling; Collagen degradation; Metalloprotease; Thyroid hormone

Indexed keywords

COLLAGENASE; COLLAGENASE 3; GELATINASE A; GELATINASE B; LIOTHYRONINE; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MATRIX; BONE METABOLISM; BONE REMODELING; COLLAGEN DEGRADATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032835375     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.277.3.e496     Document Type: Article

References (66)

1. Adlin, E. V., A. H. Maurer, A. D. Marks, and B. J. Channick. Bone mineral density in postmenopausal women treated with L-thyroxine. Am. J. Med. 90: 360-366, 1991.
2. Andress, D. L, and R. S. Birnbaum. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem. 267: 22467-22472, 1992.
3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Siedman, J. A. Smith, and K. Struhl. Current Protocols in Molecular Biology. New York: John Wiley & Sons, 1995, 4.10.1-4.10.10.
4. Banor D. T. Detrimental skeletal effects of thyrotropin suppressive doses of thyroxine: fact or fantasy? J. Clin. Endocrinol. Metab. 78: 816-817, 1994.
5. Brent, G. A. The molecular basis of thyroid hormone action. N. Engl. J. Med. 331: 847-853, 1994.
6. Britto, J. M., A. J. Fenton, W. R. Holloway, and G. C. Nicholson. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 134: 169-176, 1994.
7. Canalis, E., S. Rydziel, A. Delany, S. Varghese, and J. Jeffrey. Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136: 1348-1354, 1995.
8. Centrella, M., T. L. McCarthy, and E. Canalis. Glucocorticoid regulation of transforming growth factor β, (TGFβ) activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol. Cell. Biol. 11: 4490-4496, 1991.
9. Civitelli, R., K. A. Hruska, J. J. Jeffrey, A. J. Kahn, L. V. Avioli, and N. C. Partridge. Second messenger signaling in the regulation of collagenase production by osteogenic sarcoma cells. Endocrinology 124: 2928-2934, 1989.
10. Clohisy, J. C., T. J. Connolly, K. D. Bergman, C. O. Quinn, and N. C. Partridge. Prostanoid-induced expression of matrix metalloproteinase-1 messenger ribonucleic acid in rat osteosarcoma cells. Endocrinology 135: 1447-1454, 1994.
11. Delany, A. M., S. Rydziel, and E. Canalis. Autocrine down-regulation of collagenase-3 in rat bone cell cultures by insulin-like growth factors. Endocrinology 137: 4665-4670, 1996.
12. Edwards, D. R., P. Waterhouse, M. L. Holman, and D. T. Denhardt. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: evidence for inducible and constitutive transcripts. Nucleic Acids Res. 14: 8863-8878, 1986.
13. Ernst, M., and E. R. Froesch. Triiodothyronine stimulates proliferation of osteoblast-like cells in serum-free culture. FEBS Lett. 220: 163-166, 1987.
14. Feinberg, A., and B. Vogelstein. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 137: 266-267, 1984.
15. Fowlkes, J. L., K. M. Thrailkill, D. M. Serra, K. Suzuki, and H. Nagase. Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog. Growth Factor Res. 6:255-263, 1995.
16. Franchimont, N., D. Durant, and E. Canalis. Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology 138: 3380-3886, 1997.
17. Franchimont, N., S. Rydziel, A. M. Delany, and E. Canalis. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures. J. Biol. Chem. 272: 12144-12150, 1997.
18. Franchimont, N., S. Rydziel, and E. Canalis. Interleukin-6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J. Clin. Invest. 100: 1797-1803, 1997.
19. Freije, J. M. P., I. Diez-Itza, M. Balbin, L. M. Sanchez, R. Blasco, J. Tolivia, and C. Lopez-Otin. Molecular cloning and expression of collagenase 3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16773, 1994.
20. French, R. P., D. Warshawsky, L. Tybor, N. D. Mylniczenko, and L. Miller. Upregulation of AP-2 in the skin of Xenopus laevis during thyroid hormone-induced metamorphosis. Dev. Genet. 15: 356-365, 1994.
21. Garnero, P., V. Vassy, A. Bertholin, J. P. Riou, and P. D. Delmas. Markers of bone turnover in hyperthyroidism and the effects of treatment. J. Clin. Endocrinol. Metab. 78: 955-959, 1994.
22. Grant, D. J., J. E. McMurdo, P. A. Mole, C. R. Paterson, and R. R. Davies. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin. Endocrinol. (Oxf.) 39: 529-533, 1993.
23. Guo, C. Y., A. P. Weetman, and R. Eastell. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin. Endocrinol. (Oxf.) 46: 301-307, 1997.
24. Harvey, R. D., K. C. McHardy, I. W. Reid, F. Paterson, P. D. Bewsher, A. Duncan, and S. P. Robins. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers. J. Clin. Endocrinol. Metab. 72: 1189-1194, 1991.
25. Hasling, C., E. R. Eriksen, P. Charles, and L. Mosekilde. Exogenous triiodothyronine activates bone remodeling. Bone 8: 65-69, 1987.
26. Hill, P. A., A. J. P. Docherty, K. M. K. Bottomley, J. P. O'Connell, J. R. Murphy, J. J. Reynolds, and M. C. Meikle. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase. Biochem. J. 308: 167-175, 1995.
27. Holliday, L. S., H. G. Welgus, C. J. Fliszar, G. M. Veith, J. J. Jeffrey, and S. L. Gluck. Initiation of osteoclast bone resorption by interstitial collagenase. J. Biol. Chem. 272: 22053-22058, 1997.
28. Jeffrey, J. J., W. T. Roswit, and L. S. Ehlich. Regulation of collagenase production by steroids in uterine smooth muscle cells: an enzymatic and immunologic study. J. Cell. Physiol. 143: 396-403, 1990.
29. Kassem, M., L. Mosekilde, and E. F. Eriksen. Effects of triiodothyronine on DNA synthesis and differentiation markers of normal human osteoblast-like cells in vitro. Biochem. Mol. Biol. Int. 30: 779-788, 1993.
30. Katz, R. W., and R. J. Koenig. Nucleotide substitutions differentially affect direct repeat and palindromic thyroid hormone response elements. J. Biol. Chem. 269: 9500-9505, 1994.
31. Kawaguchi, H., C. C. Pilbeam, F. N. Woodiel, and L. G. Raisz. Comparison of the effects of 3,5,3′-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae. J. Bone Miner. Res. 9: 247-253, 1994.
32. Knauper, V., C. Lopez-Otin, B. Smith, G. Knight, and G. Murphy. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544-1550, 1996.
33. Kusano, K., C. Miyaura, M. Inada, T. Tamura, A. Ito, H. H. Nagase, K. Kamoi, and T. Suda. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139: 1338-1345, 1998.
34. Larsen, P. R., J. E. Silva, and M. M. Kaplan. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2: 87-102, 1981.
35. Leco, K. J., L. J. Hayden, R. R. Sharma, H. Rocheleau, A. H. Greenberg, and D. R. Edwards. Differential regulation of TIMP- and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblasts. Gene 117: 209-217, 1992.
36. Leco, K. J., R. Khokha, N. Pavloff, S. P. Hawkes, and D. R. Edwards. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem. 269: 9352-9360, 1994.
37. Lehmke, J., U. Bogner, D. Felsenberg, H. Peters, and H. Schleusener. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clin. Endocrinol. (Oxf.) 36: 511-517, 1992.
38. Lorenzo, J. A., C. C. Pilbeam, J. F. Kalinowsk, and M. S. Hibbs. Production of both 92- and 72-kDa gelatinases by bone cells. Matrix 12: 282-290, 1992.
39. Marcocci, C., F. Golia, G. Bruno-Bossio, E. Vignali, and A. Pinchera. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J. Clin. Endocrinol. Metab. 78: 818-823, 1994.
40. Masure, S., G. Nys, P. Fiten, J. Van Damme, and G. Opdenakker. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation. Eur. J. Biochem. 218: 129-141, 1993.
41. Matrisian, L. M., and B. L. M. Hogan. Growth factor regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Dev. Biol. 24: 219-259, 1990.
42. Mauviel, A. Cytokine regulation of metalloproteinase expression. J. Cell. Biochem. 53: 288-295, 1993.
43. Mitchell, P. G., H. A. Magna, L. M. Reeves, L. L. Lopresti-Morrow, P. J. Rosner, K. F. Geoghegan, and J. E. Hambor. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97: 761-768, 1996.
44. Morodomi, T., Y. Ogata, Y. Sasaguri, M. Morimatsu, and H. Nagase. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 firbrosarcoma cells. Biochem. J. 285: 603-611, 1992.
45. Mundy, G. R., J. L. Shapiro, J. G. Bandelin, E. M. Canalis, and L. G. Raisz. Direct stimulation of bone resorption by thyroid hormones. J. Clin. Invest. 58: 529-534, 1976.
46. Muscat, G. E., L. Mynett-Johnson, D. Dowhan, M. Downes, and R. Griggs. Activation of myoD gene transcription by 3,5,3′-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors. Nucleic Acids Res. 22: 583-591, 1994.
47. Ohishi, K., H. Ishida, T. Nagata, N. Yamauchi, C. Tsurumi, S. Nishikawa, and Y. Wakano. Thyroid hormone suppresses the differentiation of osteoprogenitor cells to osteoblasts, but enhances functional activities of mature osteoblasts in cultured rat calvaria cells. J. Cell. Physiol. 161: 544-552, 1994.
48. Partridge, N. C., J. J. Jeffrey, L. S. Ehlich, S. L. Teitelbaum, C. Fliszar, H. G. Welgus, and A. J. Kahn. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells. Endocrinology 120: 1956-1962, 1987.
49. Pernasetti, F., L. Caccavelli, C. Van de Weerdt, J. A. Martial, and M. Muller. Thyroid hormone inhibits the human prolactin gene promoter by interfering with activating protein-1 and estrogen stimulations. Mol. Endocrinol. 11: 986-996, 1997.
50. Quinn, C. O., D. K. Scott, C. E. Brinckerhoff, L. M. Matrisian, J. J. Jeffrey, and N. C. Partridge. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells. J. Biol. Chem. 265: 22342-22347, 1990.
51. Rajakumar, R. A., and C. O. Quinn. Parathyroid hormone induction of rat interstitial collagenase mRNA in osteosarcoma cells is mediated through an AP-1-binding site. Mol. Endocrinol. 10: 867-878, 1996.
52. Rifas, L., A. Fausto, M. J. Scott, L. V. Avioli, and H. G. Welgus. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 134: 213-221, 1994.
53. Roach, J., S. J. Choi, R. L. Schaub, R. J. Leach, G. D. Roodman, and S. V. Reddy. Further characterization of the murine collagenase (type IVB) gene promoter and analysis of mRNA expression in murine tissues. Gene 208: 117-122, 1998.
54. Rydziel, S., and E. Canalis. Analysis of hydroxyproline by high performance liquid chromatography and its application to collagen turnover studies in bone cultures. Calcif. Tissue Int. 44: 421-424, 1989.
55. Schmid, C., I. Schlapfer, E. Futo, M. Waldvogel, J. Schwander, J. Zapf, and E. R. Froesch. Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol. 126: 467-473, 1992.
56. Sokal, R. R., and F. J. Rohlf. Biometry (2nd ed.). San Francisco, CA: W. H. Freeman, 1981.
57. Sudo, H., H.-A. Kodama, Y. Amagai, S. Yamamoto, and S. Kasai. In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J. Cell Biol. 96: 191-198, 1983.
58. Tardif, G., J.-P. Pelletier, M. Dupuis, J. E. Hambor, and J. Martel-Pelletier. Cloning, sequencing, and characterization of the 5′-flanking region of the human collagenase-3 gene. Biochem. J. 323: 13-16, 1997.
59. Tarjan, G., and P. H. Stern. Triiodothyronine potentiates the stimulatory effects of interleukin-1 beta on bone resorption and medium interleukin-6 content in fetal rat limb bone cultures. J. Bone Miner. Res. 10: 1321-1326, 1995.
60. Tso, J. Y., X. H. Sun, T.-H. Kao, K. S. Reece, and R. Wu. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13: 2485-2502, 1985.
61. Uzzan, B., J. Campos, M. Cucherat, P. Nony, J. P. Boissel, and G. Y. Perrett. Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J. Clin. Endocrinol. Metab. 81: 4278-4289, 1996.
62. Varghese, S., A. M. Delany, L. Liang, B. Gabbitas, J. J. Jeffrey, and E. Canalis. Transcriptional and posttranscriptional regulation of interstitial collagenase by platelet-derived growth factor BB in bone cell cultures. Endocrinology 137: 431-437, 1996.
63. Varghese, S., M. L. Ramsby, J. J. Jeffrey, and E. Canalis. Basic fibroblast growth factor stimulates expression of interstitial collagenase and inhibitors of metalloproteinases in rat bone cells. Endocrinology 136: 2156-2162, 1995.
64. Wall, F. J. Statistical Data Analysis Handbook (1st ed.). New York: McGraw-Hill, 1986.
65. Williams, G. R., R. Bland, and M. C. Sheppard. Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signaling. Endocrinology 135: 2375-2385, 1994.
66. Zandomeni, R., D. Bunick, S. Ackerman, B. Mittleman, and R. Weinmann. Mechanism of action of DRB. Effect on specific in vitro initiation of transcription. J. Mol. Biol. 167: 561-574, 1983.